MSB 3.27% $1.04 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-502

  1. 2,012 Posts.
    lightbulb Created with Sketch. 565

    With safety not being an issue, what I struggle to understand is why they would NOT approve it, when no other treatment options exist.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.04
Change
-0.035(3.27%)
Mkt cap ! $1.221B
Open High Low Value Volume
$1.05 $1.05 $1.03 $1.141M 1.099M

Buyers (Bids)

No. Vol. Price($)
10 95527 $1.03
 

Sellers (Offers)

Price($) Vol. No.
$1.04 63135 5
View Market Depth
Last trade - 10.13am 30/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.